The Latest Breaking News on Pharma

Uganda will shorten the school term by two weeks to reduce daily contact amongst students and help curb the spread of Ebola, the education minister said on Tuesday.

Pressure is mounting on the federal government to expand access to fifth COVID vaccine doses, with a growing number of vulnerable Australians facing waning immunity at a time when case numbers across the country are expected to rise.

Those who took a new drug during a clinical trial were found to have significantly lower blood pressure after other traditional medicines had failed.

Scientists warn Covid jab met with ‘particular hostility’ despite evidence of safety

BioNTech, which teamed with Pfizer to develop a powerful COVID-19 vaccine, has reported that third-quarter earnings are close to half what they were a year earlier

Biopharmaceutical giant Gilead Sciences (GILD) reported better-than-expected third-quarter earnings and sales and raised its full-year guidance. Analysts see immense growth potential in the company’s HIV and oncology franchises, which should boost its performance in the upcoming quarters. Given its strong earnings, high profitability, discounted valuation, and attractive dividend, we think…

Health authorities in Uganda are struggling to contain the Ebola virus after reporting 51 deaths, including healthcare workers and 132 cases across seven districts in the country. While some government-instituted lockdowns have been put in place, the International Rescue Committee is calling for more funding to curb the spread of…

2022 has been a challenging year for investors due to the combination of inflation and a slowing economy. Biotech stocks could be a place where investors can find outperformance given their low valuations and strong long-term fundamentals. Amgen (AMGN), Corcept Therapeutics (CORT), and Regneron (REGN) are 3 to consider.

Covid-style lockdowns have been extended in Uganda with more than 50 deaths reported since the start of the outbreak.